Onion extract may lower blood sugar, cholesterol in diabetes
the ONA take:
Allium cepa, an extract found in onion bulbs, may be able to lower high blood glucose as well as total cholesterol levels in diabetes, according to a study presented at The Endocrine Society meeting in San Diego.
Investigators led by Anthony Ojieh, MD, of Delta State University in Nigeria conducted a study on rats with medically-induced diabetes, administering metformin and onion extract doses by varying doses based on body weight to three groups of rats.
They also administered the same type of treatment to three groups of rats without diabetes and normal blood sugar levels. Two final groups with and without diabetes received only metformin with no onion extract.
They found that two doses of the onion extract, at 400 and 600 mg/kg/day, greatly reduced fasting blood sugar levels in diabetic rats by 50 and 35 percent, respectively, compared with when they were not receiving the extract. Additionally, the diabetic rats undergoing these two dosages were found to have lower total cholesterol levels.
A histologic study of the pancreas that was removed from each of the diabetic rats showed that neither the metformin nor the onion extract had healed damage from the drug-induced diabetes.
“We need to investigate the mechanism by which onion brought about the blood glucose reduction,” Dr. Ojieh said. “We do not yet have an explanation.”
Allium cepa, an extract found in onion bulbs, may be able to lower high blood glucose as well as total cholesterol levels in diabetes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|